Abstract

Houlihan Lokey will report fiscal fourth-quarter results on May 6, 2026, Post Market; this preview outlines consensus expectations for revenue, margins, net income and adjusted EPS, reviews the last quarter’s performance and segment mix, and compiles prevailing analyst views heading into the print.

Market Forecast

Consensus for the current quarter centers on total revenue of 705.56 million US dollars, adjusted EPS of 1.83, and EBIT of 179.98 million US dollars, implying year-over-year increases of 12.12%, 12.70%, and 17.62%, respectively; margin guidance has not been specified in the forecasts. The core business mix remains anchored by Corporate Finance, which accounted for 66.06% of revenue last quarter, with public disclosures indicating an active mandate pipeline into fiscal fourth quarter; Financial Restructuring, which generated 156.25 million US dollars in the prior quarter, is highlighted as a meaningful swing factor supported by ongoing, widely reported advisory engagements.

The main business highlight is the breadth of the advisory franchise: Corporate Finance delivered 473.69 million US dollars last quarter, complemented by Financial and Valuation Advisory at 87.13 million US dollars, collectively underpinning the projected double‑digit year‑over‑year growth this quarter. Among segments, Financial Restructuring is positioned as a potential outperformer given continuing creditor and liability management work cited in recent headlines; segment‑specific year‑over‑year growth figures were not disclosed, but the company‑level forecast implies a supportive backdrop.

Last Quarter Review

In the most recent reported quarter, Houlihan Lokey posted revenue of 717.07 million US dollars, a gross profit margin of 94.55%, GAAP net profit attributable to shareholders of 117.00 million US dollars with a net profit margin of 16.25%, and adjusted EPS of 1.94, up 18.29% year over year. Net profit increased 4.26% quarter on quarter, while revenue exceeded the prior estimate by 15.83 million US dollars and adjusted EPS surpassed forecasts by 0.07, marking execution that translated into both top‑ and bottom‑line beats.

Main business highlights showed a balanced contribution across advisory lines: Corporate Finance was 473.69 million US dollars (66.06% of revenue), Financial Restructuring was 156.25 million US dollars (21.79%), and Financial and Valuation Advisory was 87.13 million US dollars (12.15%), collectively supporting the 13.03% year‑over‑year growth at the group level.

Current Quarter Outlook

Corporate Finance: Primary revenue engine, emphasis on conversion and fee mix

Corporate Finance remains the largest revenue contributor, delivering 473.69 million US dollars last quarter and accounting for 66.06% of the firm’s revenue. The current-quarter revenue estimate of 705.56 million US dollars, which is modestly below the seasonally strong December quarter but up 12.12% year over year, implies the firm can meet expectations with normal conversion rates on announced mandates and steady fee realization. Execution will likely hinge on closing momentum across announced transactions and the mix between completions and retainer‑based fees; even a small shift in completion timing can influence recognized revenue within the quarter. Another lever to watch is compensation alignment with revenue: maintaining a consistent compensation ratio supports margin stability even if the mix of deal sizes varies across the period.

From a practical standpoint, Corporate Finance performance in the quarter will be visible through the relationship between headcount utilization, advisory fees per engagement, and the cadence of closings. Engagement breadth matters: the firm’s diversified client set and mandate portfolio lowers dependence on any single deal or subsector, making overall performance a function of aggregated conversion rather than a handful of outsized fees. Investors will also track non‑compensation operating expenses—principally occupancy, technology, and T&E—which affect segment‑level margins through operating leverage as revenue scales. The EBIT estimate of 179.98 million US dollars, up 17.62% year over year, implicitly assumes solid operating leverage, which could be achieved if compensation and other operating costs scale below revenue growth. If deal closings skew toward later in the quarter, reported revenue could still meet the estimate, but EPS sensitivity would depend on the compensation accrual pattern and any changes in effective tax rate versus the prior quarter.

Financial Restructuring: Engagement flow signals sustained contribution potential

Financial Restructuring delivered 156.25 million US dollars in the prior quarter, representing 21.79% of total revenue. The quarter under review benefits from visible, ongoing mandates that have been publicly discussed in recent months, including creditor committee advisory roles and liability management situations. Such engagements typically involve multi‑phase scopes that can span quarters; revenue recognition depends on milestone achievements and fee schedules, which can create variability intra‑quarter but a steady contribution across a multi‑quarter horizon.

Recent headlines have referenced the firm in high‑complexity advisory roles ranging from corporate divestiture assessments to sovereign and corporate debt restructurings. While these headlines are not a guarantee of revenue timing in any single quarter, they indicate meaningful engagement breadth and persistence that reinforce the revenue base for the current period. On a consolidated basis, the firm’s forecast implies double‑digit year‑over‑year growth for revenue and adjusted EPS, and Financial Restructuring’s recurring advisory nature can help smooth fluctuations associated with large Corporate Finance completions. Monitoring disclosure around the number of active mandates, fee backlog, and timing of milestones will be critical for assessing how much of this pipeline converts during the current quarter.

For margins, Financial Restructuring tends to have a fee structure that supports attractive economics per professional hour, but compensation accruals and success‑based fee components can introduce quarter‑to‑quarter variability. The company’s gross margin profile of 94.55% last quarter underscores that direct cost of revenue remains low relative to fees, so the operating leverage for this segment primarily runs through compensation expenses. As with Corporate Finance, stable compensation management relative to revenue mix will be a key determinant of EBIT delivery against the 179.98 million US dollars estimate.

Financial and Valuation Advisory: Steady ballast with incremental expansion levers

Financial and Valuation Advisory (FVA) contributed 87.13 million US dollars last quarter, or 12.15% of total revenue. In the current quarter, FVA’s contribution is likely to remain a stabilizer for group performance, given the recurring and project‑based nature of valuation and fairness opinion work. The segment’s throughput depends on client activity levels in transactions, financial reporting valuation needs, tax and fairness opinions, and other technical assessments. Although the quarter’s consolidated forecast does not break out segment growth, the firm’s overall double‑digit year‑over‑year guide suggests FVA can help underpin revenue consistency even if completion fees in other segments vary.

Operationally, FVA margins benefit from repeat client relationships and standardized methodologies that support efficient delivery. As the firm continues to deepen relationships across corporate and sponsor clients, the FVA pipeline can expand with incremental scope across geographies and service lines. Integration of recently added teams and expertise into the broader advisory network also creates cross‑sell opportunities that may not fully materialize in one quarter but enhance medium‑term revenue durability. For the current quarter, investors should watch commentary around backlog conversion and any noted uptick in fairness opinions and valuation mandates, as these are tangible drivers that can support the consolidated revenue estimate without requiring outsized single‑deal completions.

Key stock price drivers this quarter: EPS delivery, margin discipline, and integration of recent additions

Short‑term equity performance is likely to be most sensitive to adjusted EPS relative to the 1.83 estimate and the trajectory implied for fiscal year‑end. With last quarter’s adjusted EPS at 1.94 and a year‑over‑year increase of 18.29%, the market will watch whether the current‑quarter result confirms sustained double‑digit year‑over‑year earnings growth as embedded in forecasts. A close read of the compensation expense ratio, non‑compensation operating costs, and the effective tax rate will be central to understanding the bridge from revenue and EBIT to EPS. Deviations in share count from buybacks or issuance, if any, would also affect per‑share outcomes and may draw attention during the release and call.

Margin discipline remains a central theme. The last reported gross margin of 94.55% and net margin of 16.25% establish a baseline level of profitability; investors will evaluate whether expense scaling allows EBIT to meet or exceed the 179.98 million US dollars forecast. The resilience of the net profit line will also be scrutinized given the prior quarter’s GAAP net income of 117.00 million US dollars and sequential growth of 4.26%; sustaining net margin near recent levels would signal cost alignment with revenue and stable fee realization across segments. Any update on compensation policy, particularly variable components aligned to revenue realization, could inform how margins trend if revenue timing shifts within the quarter.

Finally, integration of recently added teams and acquired boutiques remains relevant for revenue growth and expense run‑rate. Management’s commentary around how these additions are performing—measured by engagements originating from newly integrated teams, cross‑sell contributions across Corporate Finance, Restructuring, and FVA, and productivity per professional—will influence how the market interprets the durability of double‑digit growth. Investors will also parse qualitative color on the breadth of the active mandate roster mentioned publicly in recent months, as this serves as a near‑term indicator for backlog conversion, completion fees, and the mix between fixed and success‑based revenue components. In short, beat‑or‑miss dynamics on EPS, clarity on the expense trajectory, and any updates on the pipeline from newly combined teams are likely to be the most influential drivers of the share price around the print.

Analyst Opinions

The balance of recent published commentary leans bullish: aggregated analyst views cite an average rating of Overweight with a mean price target near 196 US dollars, while a recent adjustment from a major global bank maintained a Neutral stance with a 163 US dollars target. Based on this mix, the prevailing view is constructive, with bullish opinions outweighing neutral or cautious takes.

The constructive camp highlights three primary points. First, double‑digit year‑over‑year growth embedded in the consensus—12.12% for revenue and 12.70% for adjusted EPS—indicates momentum into the fiscal year‑end, supported by a diverse advisory fee base spanning Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. Second, last quarter’s performance featured both a revenue beat of 15.83 million US dollars and an EPS beat of 0.07 against estimates, alongside a 13.03% year‑over‑year revenue increase and an 18.29% rise in adjusted EPS, providing a tangible baseline that the firm can execute above consensus when backlog conversion aligns. Third, the firm’s recent visibility in publicly discussed mandates, including creditor committee advisory roles and corporate divestiture assessments, showcases engagement depth that can underpin near‑term revenue realization across more than one segment.

In framing the upside, bullish analysts point to the EBIT forecast of 179.98 million US dollars, which implies year‑over‑year operating leverage if compensation and non‑compensation costs are kept in line with revenue expectations. They also emphasize the firm’s high gross margin (94.55% last quarter) as a structural attribute, which makes the earnings trajectory most sensitive to compensation accruals, deal timing, and tax rate rather than direct cost inflation. On the revenue side, Corporate Finance’s 66.06% share last quarter provides a large base for upside if completion activity in the quarter clears at a healthy rate; meanwhile, Financial Restructuring’s contribution of 156.25 million US dollars in the prior quarter adds ballast from multi‑phase mandates that often span multiple reporting periods.

In contrast, the neutral view—illustrated by the 163 US dollars price target—reflects prudence around short‑term normalization in advisory activity and valuation after a period of strong growth, without disputing the durability of the platform. Even within that framing, the estimate set for revenue and earnings suggests the firm remains positioned to deliver double‑digit year‑over‑year growth this quarter. Consequently, the preponderance of the recent visible commentary supports a positive skew into the print, with the majority viewpoint focusing on the company’s ability to convert its active mandate roster into revenue, manage expenses to preserve margin, and translate operating performance into steady per‑share earnings growth.